CHEST, the annual meeting of the American College of Chest Physicians, was held October 16-19, 2022, in Nashville, Tennessee. Here are some key takeaways from the meeting.
Pulmonary Embolism Treatments Are Evolving, Says Dr Parth Rali
Parth Rali, MD, an associate professor of thoracic medicine and surgery at the Lewis Katz School of Medicine, director at Temple Health System Pulmonary Embolism Response Team (PERT), and chair of the national PERT Consortium Protocol Committee, discussed the latest randomized trials of catheter-based treatments for acute pulmonary embolism, as well as the key takeaways patients and clinicians should know.
Targeting the Youth Vaping Epidemic and Its Adverse Health Effects
During a panel, experts spoke on the rise of e-cigarette use among youth and young adults in the United States, including how sleek designs and flashy colors are directly targeting younger audiences.
Understanding the Tsunami of Evidence for COVID-19 Treatments
The ability to manage care when it comes to COVID-19 and its “tsunami of evidence” on additional treatments is necessary as knowledge evolves, but represents a challenge for many physicians, said experts on a panel.
Patients With Uncontrolled Asthma May Need to Be Considered for Triple Therapy, Posters Find
Researchers presented 2 posters reviewing how patients with uncontrolled asthma may benefit from taking dual or triple therapies, finding those patients had improved outcomes after escalating to triple therapy.
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More